The latest price target for Molina Healthcare (NYSE:MOH) was reported by Cantor Fitzgerald on September 10, 2024. The analyst firm set a price target for $406.00 expecting MOH to rise to within 12 months (a possible 14.32% upside). 32 analyst firms have reported ratings in the last year.

The latest analyst rating for Molina Healthcare (NYSE:MOH) was provided by Cantor Fitzgerald, and Molina Healthcare reiterated their overweight rating.

The last upgrade for Molina Healthcare Inc happened on February 15, 2024 when Wells Fargo raised their price target to $420. Wells Fargo previously had an underweight for Molina Healthcare Inc.

The last downgrade for Molina Healthcare Inc happened on April 1, 2024 when B of A Securities changed their price target from N/A to $439 for Molina Healthcare Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Molina Healthcare, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Molina Healthcare was filed on September 10, 2024 so you should expect the next rating to be made available sometime around September 10, 2025.

While ratings are subjective and will change, the latest Molina Healthcare (MOH) rating was a reiterated with a price target of $406.00 to $406.00. The current price Molina Healthcare (MOH) is trading at is $355.15, which is out of the analyst’s predicted range.